SUMMARY The proteins present in 4% polyethylene glycol (PEG) precipitates of 10 normal sera and 60 samples from patients with rheumatic diseases were studied. A variety of immunochemical methods were used, including estimation of the percentages of total serum proteins precipitated by PEG, gel filtration analyses of the precipitates, and affinity chromatography with protein A and anti-immunoglobulin columns. Substantial amounts of protein were precipitated from normal sera. Many non-immunoglobulin proteins were precipitated from patients' sera, including fibronectin, haptoglobin, albumin, transferrin, and ac-antitrypsin. Affinity chromatography with anti-immunoglobulin columns bound non-immunoglobulin proteins from PEG precipitates, but the protein A affinity column did not do so. The view that circulating antibody-antigen complexes alone are precipitated by 4% PEG is too simplistic; many non-immunoglobulin proteins are involved. They may either bind to immune complexes or be coprecipitated owing to non-specific protein aggregation.
Polyethylene glycol (PEG) precipitation is the basis for several techniques for the detection and measurement of circulating immune complexes."' Doubts have been expressed about the specificity of PEG precipitation for this purpose,5 and there is still controversy about several points"8-namely, the proportions in which the main classes of immunoglobulins occur in PEG precipitates; which other plasma proteins accompany the immunoglobulins in significant amounts; and what role (if any) these other proteins may have in complex formation or elimination. We looked at a series of 4% PEG precipitates from patients with rheumatic disorders and healthy controls using a variety of immunochemical techniques to re-examine these questions. Gel filtration Sephacryl S400 superfine (Pharmacia) was used for gel filtration chromatography in Wright Amicon columns of bed volume 684 ml. The void volume (242 ml) was determined with Blue Dextran 2000. The sample volume of serum or resuspended PEG precipitate applied to the columns was 3 ml. The optical density of the eluate was measured at 280 nm. Fractions (6 ml) were collected and those eluted between 240 and 600 ml stored at -20°C until analysed.
Patients and methods

PATIENTS
AFFINITY CHROMATOGRAPHY
Two techniques, based on the methods of Johnstone and Thorpe were used.'4 Firstly, protein A-Sepharose CL-4B (Pharmacia), as a preformed column, was used to bind IgG. The running buffer was 0-2 mM phosphate pH 7-0 and the eluting buffer 0-1 M glycine-HCl pH 3-0. Secondly, specific antiIgG, -IgA, and -1gM columns, containing the respective antisera covalently bound to Sepharose 4B activated by cyanogen bromide, were used for these individual immunoglobulins. Three columns were set up in series (one for each immunoglobulin) with a running buffer of 0-5 M sodium chloride containing 20 mM sodium dihydrogen orthophosphate pH 7-3. Proteins were eluted with 3 M potassium thiocyanate in 0-5 M ammonium hydroxide.
Samples were passed through a Sepharose 4B column to remove proteins bound non-specifically, and then 0-5 ml of serum or redissolved PEG precipitate, thus pretreated, was loaded onto the affinity columns. After elution the material detected in the main peaks was pooled and dialysed against phosphate buffered saline for 48 hours at 40C with three changes of buffered saline. The samples were gently concentrated back to their starting volumes using Sartorius collodion bags and a vacuum of67 kPa. The samples were stored at -20°C until their Table 2 Amounts of immunoglobulin and fibronectin in polyethylene glycol precipitates in different diagnostic groups. (1-0 to 2-0) 4.3 (2-2 to 6-4) [3] [4] [5] [6] (1.9 to protein concentrations were estimated immunochemically.
IMMUNOCHEMICAL ESTIMATION
IgG, IgA, IgM, haptoglobin, complement C3, alantitrypsin, transferrin, and albumin were determined by radial immunodiffusion. Rocket immunoelectrophoresis was used to estimate fibronectin. The monospecific antisera necessary for these estimations were obtained from Dakopatts Ltd. A standard of suitably diluted pooled human serum was used in determining each protein. The standard serum was previously calibrated with a highly purified sample of the appropriate protein.
The concentration of each protein in serum or PEG precipitate was expressed as a percentage of its level in the standard serum (as g/l or mg/l). 
Results
Small amounts of protein were precipitated from control sera by 4% PEG. About twice as much protein was precipitated from the patients' sera ( Table 2 ). There were similar increases in the amounts of immunoglobulins and fibronectin in the precipitates. Subdivision of the patients into different diagnostic categories showed that most PEG precipitate was present in the five cases of RA vasculitis with or without Felty's syndrome. The least PEG precipitate was present in the seven patients with other forms of immune vasculitis.
More detailed analyses were undertaken in five patients and one control. The total amounts of Affinity chromatography with anti-immunoglobulins showed a different pattern of binding (Table 5 ). Non-immunoglobulin proteins were bound from all patients' sera and in many instances from PEG precipitates.
Discussion
If4% PEG preferentially precipitates only circulating >1000 100-1000 10-100 1-10 ND* >1000 100-1000 10-100 .1-10 ND The optimal concentration of PEG for these assays is the subject of debate. Although many workers use 4% PEG, other groups prefer lower concentrations, such as 2% or 2-5% PEG. In a large initial study we evaluated the effectiveness in this assay of four different concentrations of PEG from 1 6 to 4.0%. 5 We found that lower concentrations of PEG are considerably less sensitive, but it has been argued that they are more specific. Our own view is that 4% PEG has the advantage of sensitivity in determining the constituents of putative complexes. In vitro studies with one non-immunoglobulin protein found in PEG precipitates, fibronectin, have shown that the purified protein alone is not precipitated by 4% PEG. '6 Non-immunoglobulin proteins could be present in PEG precipitates owing to 'trapping' or non-specific binding to the columns, but the evidence suggests this is not the case. The washing procedure we used was extensive. The proteins were present in association with immunoglobulins in high molecular weight fractions of sera and PEG precipitates. They were eluted from the anti-immunoglobulin column after affinity chromatographic analysis of PEG precipi- There were clear differences between the type of proteins eluted from the protein A affinity column and the anti-immunoglobulin affinity columns. It was only with the latter columns that non-immunoglobulin proteins were bound from PEG precipitates. The implication behind this finding is that nonimmunoglobulin proteins are associated with certain immunoglobulins, but not the IgG which binds to protein A. If sera contains circulating immune complexes it may be that several different types of complex are present, only some of which bind small amounts of other plasma proteins.
There were interesting differences between subgroups of patients (Table 2 ). Rheumatoid vasculitis differed quite markedly from the other cases of 'immune' vasculitis. Only patients with rheumatoid vasculitis had large amounts of PEG precipitable immunoglobulins. Clearly different pathological mechanisms must exist in these two groups, and it is unlikely that circulating immune complexes are the basis of the vascular damage in patients with conditions like polyarthritis nodosa.
Our principal objective was to reconsider exactly what 4% PEG precipitates contain. Many nonimmunoglobulin serum proteins are precipitated by it, and other methods like gel filtration and affinity chromatography suggest that these proteins are closely associated with immunoglobulins. Either circulating immune complexes bind many different proteins or non-specific protein aggregation is common. In both cases the simplistic views that PEG specifically precipitates circulating immune complexes is incorrect.
